Crude Oil Edges Lower; US Wholesale Inventories Rise 0.1% In August
U.S. Stock Market Performance: U.S. stocks rose, with the Dow Jones gaining over 350 points, while financial shares increased by 1%. However, communication services shares fell by 0.8%.
Economic Indicators: U.S. wholesale inventories saw a slight increase of 0.1% in August, and mortgage applications dropped by 5.1% in early October. Meanwhile, Germany's trade surplus exceeded expectations, and Asian markets closed mostly lower.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on IKT
About IKT
About the author
INHIBIKASE THERAPEUTICS INC: BOFA GLOBAL RESEARCH STARTS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $6
Company Overview: Inhibikase Therapeutics is a biotechnology company focused on developing treatments for neurodegenerative diseases.
Recent Developments: The company has received a "Buy" rating from analysts, indicating positive expectations for its future performance.
Intuit Shares Rise: 20 Stocks Making Moves in Premarket Trading
Intuit's Financial Performance: Intuit Inc. reported better-than-expected first-quarter results, with revenue of approximately $3.89 billion and adjusted earnings of $3.34 per share, leading to a 3.2% increase in share price during pre-market trading.
Second-Quarter Expectations: The company anticipates second-quarter revenue growth of 14% to 15% and adjusted earnings between $3.63 and $3.68 per share, which is below analyst estimates.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, including Nuvve Holding Corp, which surged 49.4%, and Enviri Corp, which gained 31.5% after announcing a major sale.
Declines in Other Stocks: Conversely, Pasithea Therapeutics Corp experienced a notable decline of 25.3% following the release of interim trial data, alongside other stocks like Safe & Green Holdings Corp and VisionSys AI Inc, which also saw significant drops.
